Avivagen Stock Analysis
| VIV Stock | CAD 0.01 0.00 0.00% |
Avivagen is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Avivagen stock analysis is to determine its intrinsic value, which is an estimate of what Avivagen is worth, separate from its market price. There are two main types of Avivagen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Avivagen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Avivagen's stock to identify patterns and trends that may indicate its future price movements.
The Avivagen stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Avivagen is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day, Civic Holiday, Labour Day. Avivagen Stock trading window is adjusted to America/Toronto timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Avivagen's ongoing operational relationships across important fundamental and technical indicators.
Avivagen |
Avivagen Stock Analysis Notes
The company recorded a loss per share of 0.06. Avivagen last dividend was issued on the 25th of May 2017. The entity had 1:10 split on the 25th of May 2017. Avivagen Inc. develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animals own health defenses. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. AVIVAGEN INC operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on TSX Venture Exchange. It employs 13 people. For more information please call Cameron Groome at 613-702-2908 or visit https://www.avivagen.com.Avivagen Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Avivagen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Avivagen or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Avivagen generated a negative expected return over the last 90 days | |
| Avivagen has some characteristics of a very speculative penny stock | |
| Avivagen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 939.17 K. Net Loss for the year was (6.07 M) with profit before overhead, payroll, taxes, and interest of 400.3 K. | |
| Avivagen has accumulated about 3.23 M in cash with (3.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Closing Bell Avivagen Inc flat on Tuesday - The Globe and Mail |
Avivagen Largest EPS Surprises
Earnings surprises can significantly impact Avivagen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-03-16 | 2023-01-31 | -0.02 | -0.01 | 0.01 | 50 | ||
2023-01-31 | 2022-10-31 | -0.02 | -0.01 | 0.01 | 50 | ||
2022-09-16 | 2022-07-31 | -0.02 | -0.03 | -0.01 | 50 |
Avivagen Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 388.47 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avivagen's market, we take the total number of its shares issued and multiply it by Avivagen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Avivagen Profitablity
Avivagen's profitability indicators refer to fundamental financial ratios that showcase Avivagen's ability to generate income relative to its revenue or operating costs. If, let's say, Avivagen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Avivagen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Avivagen's profitability requires more research than a typical breakdown of Avivagen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.00) | (4.20) | |
| Return On Capital Employed | 1.46 | 2.28 | |
| Return On Assets | (4.00) | (4.20) | |
| Return On Equity | 1.17 | 0.59 |
Management Efficiency
Avivagen has return on total asset (ROA) of (1.9344) % which means that it has lost $1.9344 on every $100 spent on assets. This is way below average. Avivagen's management efficiency ratios could be used to measure how well Avivagen manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to climb to 2.28 in 2024, whereas Return On Tangible Assets are likely to drop (4.20) in 2024. At this time, Avivagen's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 148.9 K in 2024, whereas Intangible Assets are likely to drop 347.99 in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.08) | (0.09) | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | (0.08) | (0.09) | |
| Enterprise Value Over EBITDA | (20.44) | (19.42) | |
| Price Book Value Ratio | (1.39) | (1.32) | |
| Enterprise Value Multiple | (20.44) | (19.42) | |
| Price Fair Value | (1.39) | (1.32) | |
| Enterprise Value | 13.5 M | 11.5 M |
The analysis of Avivagen's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Avivagen's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Avivagen Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.079 |
Technical Drivers
In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Avivagen, as well as the relationship between them. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate zero technical drivers for Avivagen, which can be compared to its peers.Avivagen Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Avivagen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Avivagen. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Avivagen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Avivagen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avivagen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Avivagen. By using and applying Avivagen Stock analysis, traders can create a robust methodology for identifying Avivagen entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (5.81) | (6.10) | |
| Operating Profit Margin | (0.89) | (0.94) | |
| Net Loss | (5.81) | (6.10) | |
| Gross Profit Margin | 0.49 | 0.77 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Avivagen to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Avivagen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Avivagen Stock analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |